Payers are achieving success with outcome-based contracts (OBCs), according to a survey published by Washington, D.C.-based consulting firm Avalere Health on Oct. 1. That’s despite perceived operational challenges (such as the capacity of personnel needed to do analytics and case management), lack of real-world evidence around the efficacy of new devices and therapies, and the regulatory issues associated with implementation (such as “best price” and anti-kickback statutes).
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.